[PANAMY] YoY Annual (Unaudited) Result on 31-Mar-2015 [#4]

Stock
[PANAMY] PANASONIC MANUFACTURING MSIA
Announcement Date
27-May-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Mar-2015
Quarter
31-Mar-2015 [#4]
Profit Trend
YoY- 23.21%
Quarter Report
Latest QR
Upcoming QR
PANAMY's Result
PANAMY's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Revenue 1,199,120 1,122,964 1,086,735 931,020 899,211 864,645 825,833 6.41%
PBT 166,303 158,099 185,172 129,833 105,199 94,930 85,211 11.78%
Tax -35,287 -30,981 -38,272 -30,295 -24,414 -19,836 -18,804 11.05%
NP 131,016 127,118 146,900 99,538 80,785 75,094 66,407 11.98%
-
NP to SH 131,016 127,118 146,900 99,538 80,785 75,094 66,407 11.98%
-
Tax Rate 21.22% 19.60% 20.67% 23.33% 23.21% 20.90% 22.07% -
Total Cost 1,068,104 995,846 939,835 831,482 818,426 789,551 759,426 5.84%
-
Net Worth 881,424 821,893 779,371 718,625 663,346 668,206 647,552 5.27%
Dividend
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Div 150,650 9,111 84,436 9,111 9,111 114,202 9,111 59.57%
Div Payout % 114.99% 7.17% 57.48% 9.15% 11.28% 152.08% 13.72% -
Equity
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Net Worth 881,424 821,893 779,371 718,625 663,346 668,206 647,552 5.27%
NOSH 60,746 60,746 60,746 60,746 60,746 60,746 60,746 0.00%
Ratio Analysis
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
NP Margin 10.93% 11.32% 13.52% 10.69% 8.98% 8.68% 8.04% -
ROE 14.86% 15.47% 18.85% 13.85% 12.18% 11.24% 10.26% -
Per Share
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
RPS 1,973.99 1,848.62 1,788.98 1,532.64 1,480.28 1,423.38 1,359.49 6.41%
EPS 216.00 209.00 242.00 164.00 133.00 124.00 109.00 12.06%
DPS 248.00 15.00 139.00 15.00 15.00 188.00 15.00 59.57%
NAPS 14.51 13.53 12.83 11.83 10.92 11.00 10.66 5.27%
Adjusted Per Share Value based on latest NOSH - 60,746
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
RPS 1,944.26 1,820.78 1,762.03 1,509.56 1,457.98 1,401.94 1,339.01 6.41%
EPS 212.43 206.11 238.18 161.39 130.99 121.76 107.67 11.98%
DPS 244.26 14.77 136.91 14.77 14.77 185.17 14.77 59.58%
NAPS 14.2914 13.3262 12.6367 11.6518 10.7555 10.8343 10.4994 5.27%
Price Multiplier on Financial Quarter End Date
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Date 30/03/18 31/03/17 31/03/16 31/03/15 31/03/14 29/03/13 30/03/12 -
Price 34.60 34.90 29.68 23.20 21.94 21.78 22.00 -
P/RPS 1.75 1.89 1.66 1.51 1.48 1.53 1.62 1.29%
P/EPS 16.04 16.68 12.27 14.16 16.50 17.62 20.12 -3.70%
EY 6.23 6.00 8.15 7.06 6.06 5.68 4.97 3.83%
DY 7.17 0.43 4.68 0.65 0.68 8.63 0.68 48.05%
P/NAPS 2.38 2.58 2.31 1.96 2.01 1.98 2.06 2.43%
Price Multiplier on Announcement Date
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Date 21/05/18 30/05/17 30/05/16 27/05/15 30/05/14 30/05/13 30/05/12 -
Price 38.30 36.34 29.70 21.80 22.68 25.12 23.00 -
P/RPS 1.94 1.97 1.66 1.42 1.53 1.76 1.69 2.32%
P/EPS 17.76 17.37 12.28 13.30 17.05 20.32 21.04 -2.78%
EY 5.63 5.76 8.14 7.52 5.86 4.92 4.75 2.87%
DY 6.48 0.41 4.68 0.69 0.66 7.48 0.65 46.67%
P/NAPS 2.64 2.69 2.31 1.84 2.08 2.28 2.16 3.39%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment